Sarah Cannon - Texas Transplant Institute at Methodist Hospital

Clinical research site in San Antonio, Texas

As of July 2026, 1 paid clinical trial is recruiting at Sarah Cannon - Texas Transplant Institute at Methodist Hospital in San Antonio, Texas. Active studies at this site focus on B-cell Acute Lymphoblastic Leukemia alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Sarah Cannon - Texas Transplant Institute at Methodist Hospital (1)

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

for B-cell Acute Lymphoblastic Leukemia

13 locations incl. Los Angeles

Sponsor: Cellectis S.A.

Sex: All·Age: 15 - 50

Code: NCT04150497·Phase 1, Phase 2·Recruiting·Listed Nov 2019

Apply to this trial

More research sites in San Antonio

University of Texas Health Science Center at San Antonio (85 trials)
NEXT Oncology (56 trials)
Children's Hospital of San Antonio (32 trials)
Methodist Children's Hospital of South Texas (24 trials)
START San Antonio (22 trials)
The University of Texas Health Science Center at San Antonio (21 trials)
UT Health San Antonio (16 trials)
GSK Investigational Site (13 trials)
Texas Dermatology and Laser Specialists (13 trials)
Texas Oncology - San Antonio (12 trials)

Explore more

Paid clinical trials in San Antonio, TX · Texas clinical trials